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Abstract
Fat storage-Inducing Transmembrane proteins 1 & 2 (FIT1/FITM1 and FIT2/FITM2) belong to a unique family of
evolutionarily conserved proteins localized to the endoplasmic reticulum that are involved in triglyceride lipid droplet
formation. FIT proteins have been shown to mediate the partitioning of cellular triglyceride into lipid droplets, but not
triglyceride biosynthesis. FIT proteins do not share primary sequence homology with known proteins and no structural
information is available to inform on the mechanism by which FIT proteins function. Here, we present the experimentally-
solved topological models for FIT1 and FIT2 using N-glycosylation site mapping and indirect immunofluorescence
techniques. These methods indicate that both proteins have six-transmembrane-domains with both N- and C-termini
localized to the cytosol. Utilizing this model for structure-function analysis, we identified and characterized a gain-of-
function mutant of FIT2 (FLL(157-9)AAA) in transmembrane domain 4 that markedly augmented the total number and
mean size of lipid droplets. Using limited-trypsin proteolysis we determined that the FLL(157-9)AAA mutant has enhanced
trypsin cleavage at K86 relative to wild-type FIT2, indicating a conformational change. Taken together, these studies indicate
that FIT2 is a 6 transmembrane domain-containing protein whose conformation likely regulates its activity in mediating lipid
droplet formation.
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Introduction
The ability to store triglycerides and other non-polar lipids in
cytosolic lipid droplets is a ubiquitous biochemical attribute of
eukaryotes. Lipid droplets consist of a core of neutral lipids
surrounded by a phospholipid monolayer and an associated
proteome, of which the perilipin family [1], triacylglyceride and
diacylglyceride lipases [2], CGI-58 [3], and Fsp27 [4,5] are some
of the best characterized lipid droplet-associated proteins to date.
Lipid droplets play an important role in the maintenance of energy
homeostasis, serving as a dense energy reservoir during starvation
conditions. Under conditions of excessive energy intake, triglyc-
eride accumulation can lead to obesity and associated diseases
such as type 2 diabetes, cardiovascular disease, and metabolic
syndrome [6].
Lipid droplet catabolism is highly regulated. In adipocytes, lipid
droplet triglyceride hydrolysis is mediated by the lipases
desnutrin/ATGL/PNPLA2, hormone sensitive lipase and by
other lipid droplet-associated proteins, such as the perilipin family
and CGI-58 [1,2,3]. Recently, the involvement of autophagy has
been implicated in lipid droplet catabolism in hepatocytes [7],
adding to the complexity of mechanisms that play a role in
regulating lipid droplet turnover. Conversely, little information is
known about the process of lipid droplet formation. The physical
process of forming lipid droplets is thought to occur at or within
the endoplasmic reticulum (ER) membrane [8]. Several forward
genetic screens have been conducted in model organisms or cells
to identify proteins important in lipid droplet metabolism and have
surprisingly revealed that more than 1% of genes in eukaryotic
genomes are involved in lipid droplet biology [9,10,11]. These
genetic screens have identified proteins that are involved in
regulating lipid droplet lipolysis, neutral lipid biosynthesis, and
various other factors which do not yet have assigned roles in lipid
droplet biology. Many of these undefined factors may eventually
be characterized as having roles in lipid droplet formation.
We have recently described the identification of an evolution-
arily conserved family of ER-resident membrane proteins that we
named Fat-Inducing Transcripts 1 & 2 which have since been re-
named Fat storage-Inducing Transmembrane proteins 1 & 2
(FIT1/FITM1 and FIT2/FITM2) [12]. FIT2 is anciently
conserved back to S. cerevisiae, while FIT1 is found only as far
back as boney fish. FIT1 is primarily expressed in skeletal muscle,
with lower levels found in heart, and FIT2 is ubiquitously
expressed in tissues, with the highest levels in white and brown
adipose tissue.
FIT proteins are not located on lipid droplets, but exclusively
found in the ER, the presumed site of lipid droplet formation. As
the name implies, when these proteins are expressed in cells or in
mouse liver, they induce triglyceride droplet accumulation without
inducing triglyceride biosynthesis—an enzymatic reaction carried
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10796out by the diacylglycerol O-acyltransferase (DGAT) family of ER-
resident membrane proteins [13,14,15]. Additionally, FIT proteins
do not play a known role in lipolysis [12]. Knockdown of FIT2 in
3T3-L1 adipocytes or in zebrafish resulted in a significant decrease
in lipid droplet accumulation, indicating an important role of FIT2
in lipid droplet accumulation in these models.
FIT proteins are unique in their biochemical mode of action in
that they mediate the partitioning of triglyceride from the ER into
cytosolic lipid droplets [12]. However, the mechanism by which
FIT proteins mediate this process is not known. An impediment to
understanding this process is the fact that FIT proteins do not
share homology to known proteins or protein domains, making it
difficult to infer a mechanism based on primary sequence. In
addition, no structural information is available for FIT proteins to
date. To gain a better understanding of the mechanism by which
FIT proteins operate, we present here experimentally determined
topological models for this unique family of proteins followed by
structure-function analysis of the anciently conserved FIT2 protein
revealing a specific group of conserved amino acids that play an
important role in regulating FIT2 conformation and function.
Results
FIT1 and FIT2 are six-transmembrane-domain-containing
proteins
FIT1 and FIT2 comprise a unique family of proteins that do not
have homology to known proteins or protein domains found in
any species. In order to create a foundation for structure-function
analysis of FIT proteins, we sought to create a topological model of
FIT proteins by first examining FIT2 as the archetype of the FIT
family of proteins since it is the more ancient and conserved form
and is expressed in all mammalian tissues, with the highest levels in
white and brown adipose tissue [12]. The topology of FIT2 was
previously predicted by the TMHMM algorithm to contain either
five or six transmembrane domains [12].
In order to determine the orientation of the N- and C-terminus
and the number and orientation of transmembrane domains, we
performed epitope tag-glycosylation site mapping, a method that
was successfully used to determine the topology of the ER-resident
multispanning membrane protein Insig-1 [16]. In this method, a
glycosylation consensus motif can be engineered into predicted
cytosolic and luminal portions of ER-resident membrane proteins.
Only inserted motifs that are exposed to the ER lumen can
become accessible to glycosyltransferases in the ER; therefore,
glycosylation indicates a luminal orientation. A glycosylation
consensus sequence (NGT) flanked by a FLAG tag
(DYKDDDDK) on each side (FLAG-NGT-FLAG, abbreviated
FNF) was inserted into each of the possible luminal and cytosolic
loops of C-terminally V5- and polyhistidine-tagged FIT2 (desig-
nated FIT2-V5, Fig. 1A). Each of these constructs was expressed in
HEK293 cells and all were functional in terms of the ability to
form lipid droplets (Fig. S1). Western blot analysis showed that
FNF tags inserted at amino acid positions 51, 129 and 217 resulted
in molecular weight shifts greater than the 19 amino acid addition
of the FNF tag, likely indicating glycosylated FIT2-V5 (Fig. 1B).
Insertions at amino acids 13, 84, 177, and 254 did not result in
molecular weight shifts corresponding to greater than 19 amino
acids–the molecular weight of the FNF tag (Fig. 1B). To prove that
these molecular weight shifts were the consequence of glycosyla-
tion, cell lysates were treated with the endoglycosidase PNGaseF in
order to cleave N-linked glycans. Lysates from cells expressing
FIT2 constructs with FNF insertions at positions 51, 129, and 217
that were treated with PNGase F decreased in molecular weight,
consistent with glycosylation and the localization of these domains
to the ER lumen. PNGaseF treatment did not affect the apparent
molecular weight of FNF insertions at 13, 84, 177, or 254,
indicating that these loops are cytosolic (Fig. 1B).
Murine FIT1 and FIT2 are 35% identical and 50% similar
[ 1 2 ] ;h o w e v e r ,F I T 1( 2 9 2a m i n oa c i d s )h a s3 0e x t r aa m i n oa c i d s
a ti t sN - t e r m i n u sa n dh a sl i m i t e dh o m o l o g yw i t hF I T 2( 2 6 2
amino acids) in transmembrane domain 1. Furthermore, Kyte-
Doolittle plots and TMHMM prediction models conflicted in
the definition of transmembrane domain regions [12]. The
reason for this is that the extra 30 amino acids at the N-terminus
comprises a hydrophobic tract of amino acids that could be a
seventh transmembrane domain or exist as a cytosolic domain.
Therefore, we sought to confirm the topological model for the
most poorly aligned part of FIT1. Using a similar approach for
determining FIT2 topology, FNF tags were inserted at amino
acid positions 8, 48, and 87 of FIT1 (Fig. 1C). Each construct
was transiently expressed in HEK293 cells and tested for the
presence of glycosylation as described above. When an FNF
insertion was made at amino acid 8, FIT1-V5 mobility is
reduced on SDS-PAGE, suggesting glycosylation (Fig. 1D).
However, PNGaseF treatment clearly indicated that FNF at
position 8 was not glycosylated, but that FNF at position 87 was
glycosylated (Fig. 1D). The molecular weight shift observed for
the FNF construct at position 8 suggests a structured N-terminus
of FIT1 that is altered by this particular FNF insertion (Fig. 1D).
These experiments showed that the FIT1 N-terminus and
domains containing FNF insertions at amino acids 8 and 48
were not glycosylated, and thus likely exposed to the cytosol,
while the domain containing a FNF tag at amino acid 87 was
glycosylated, indicating that it is located in the ER lumen
(Fig. 1D).
To confirm the orientation of each transmembrane domain of
FIT2 and FIT1 by an independent method, we used selective
permeabilization of the plasma membrane in conjunction with
indirect immunofluorescence microscopy to the FLAG epitope in
each FNF construct. At low concentrations of digitonin (20 mM),
only the plasma membrane, and not the ER can be permeabi-
lized [17], while in the presence of 0.1% Triton X-100, both
plasma membrane and ER membranes are permeabilized. We
confirmed in our assays that we were achieving plasma
membrane-selective permeabilization using the endogenously
expressed ER-resident membrane protein calnexin as a control
(Fig. S2). HEK293 cells were transiently transfected with each
FIT2-V5 or FIT1-V5 FNF construct described above and were
processed for indirect immunofluorescence using digitonin
treatment with or without Triton X-100. Indirect immunofluo-
rescence microscopy studies clearly confirmed the glycosylation
studies (Fig. 2A, B) and indicated that the six-transmembrane
domain topological models of both FIT1 and FIT2 were correct,
in which both proteins have their N- and C-termini facing the
cytosol (Fig. 1A, C).
Identification of a FIT2 Gain-of-Function Mutant
Transmembrane domain 4 of FITs contains the most highly
conserved residues throughout the FIT protein family which can
be considered a FIT signature sequence (Fig. 3). Using FIT2-V5 as
an archetype for our studies of FIT function, we performed
alanine mutagenesis on this domain. Single or paired conserved
residues were mutated to alanine, expressed in HEK293 cells, and
lipid droplets were visualized by fluorescence confocal microscopy
in order to characterize alterations in phenotype. To visualize lipid
droplets we utilized the neutral lipid fluorescent dye BODIPY
493/503, commonly used to visualize and quantify lipid droplets
due to its high specificity for lipid droplets [18]. This stain was
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genetic screen to identify genes important in lipid droplet biology
[10]. In order to determine that cells having lipid droplets
expressed FIT2, FIT2 expressing cells were identified by
immunofluorescence. Of the mutants generated, FLL(157-9)AAA
(abbreviated as FLL) showed a pattern of increased number of
lipid droplets and larger lipid droplets compared to wild-type FIT2
when subjected to BODIPY 493/503 staining and confocal
fluorescence microscopy (Fig. 4A). The observed lipid droplet
phenotype of cells expressing FLL could not be explained by either
expression level of FLL relative to wild-type FIT2, its subcellular
localization (Fig. 5 lanes 1 & 2, Fig. S3, and Fig. S5), or
transfection efficiency (90% for both wild-type and FLL). Mock
transfected cells served as a negative control for lipid droplet
staining, since HEK293 cells rarely exhibited lipid droplets.
DGAT2 overexpression served as a positive control and resulted in
an abundance of small lipid droplets. Quantification of lipid
droplet number and size clearly indicated that expression of the
Figure 1. Membrane topology of murine FIT2 and FIT1. A and C, FIT2 and FIT1 topological models with N- and C-termini oriented toward the
cytosol and six transmembrane domains with a large second luminal loop. The amino acid positions of insertion of FNF tags for the determination of
topology by glycosylation site mapping and indirect immunofluorescence are indicated. As indicated, all constructs contain C-terminal V5 and
polyhistidine epitope tags. B and D, Increased molecular weights of specific FNF-V5 constructs relative to wild-type FIT2 or FIT1 (indicated by
asterisks) detected by Western blot analysis indicated potential glycosylation and luminal orientation. Decreased molecular weight of constructs
following PGNaseF treatment indicated glycosylation and luminal orientation. Asterisks indicate glycosylated forms of FIT2 and FIT1 constructs. The
multiple asterisks indicated for the FIT2 construct 51 is due to two tandem FNF glycosylation sites inserted into that construct (arrow indicates non-
glycosylated construct 51). B and D are representative of two independent experiments.
doi:10.1371/journal.pone.0010796.g001
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(WT, 0.860.2 mm
3; FLL, 4.060.3 mm
3; p=3.68610
26) (Fig. 4B)
and a 5-fold increase in lipid droplet number compared to cells
expressing wild-type FIT2 (Fig. 4C). As expected, mock-transfect-
ed cells rarely exhibited droplets, while DGAT2-expressing cells
had an average of 21 small lipid droplets per cell (average volume,
0.5560.08 mm
3) (Fig. 4B, C). Despite the 5-fold increase in both
lipid droplet number and size in cells expressing FLL mutant,
triglyceride levels were only increased 1.8-fold compared to cells
expressing WT FIT2. Triglyceride levels in cells expressing FLL or
WT FIT2 were moderately increased relative to mock-transfected
control cells (3-fold and 1.6-fold, respectively) compared to the
greater than 10-fold increase in cells expressing DGAT2 (Fig. 4D).
This finding is consistent with our previous finding that FIT2 does
not mediate triglyceride biosynthesis, a biochemical function
mediated by the DGAT enzymes [13], but rather mediates the
partitioning of cellular triglycerides into lipid droplets [12]. No
significant changes in various phospholipid species were found
(Fig. 4D). Taken together, the data indicate that the FLL mutation
imparts a gain-of-function on FIT2 resulting in increased lipid
droplet accumulation.
FLL(157-9)AAA FIT2 has a conformational change
We next sought to explain the gain-of-function phenotype of the
FLL mutant. We hypothesized that the FLL mutant has an
activating conformational change relative to wild-type FIT2. We
tested this hypothesis using a limited trypsin digestion method
previously used to determine conformational changes in ER-
resident polytopic membrane proteins in response to lipids [19,20].
The readout for this technique is to simply identify any alteration
in trypsin resistant fragments by Western blot analysis using an
antibody to a luminal domain encompassing a trypsin resistant
epitope. Therefore, changes in tryptic digestion pattern are a
surrogate marker for changes in protein conformation.
Taking advantage of our experimentally determined topological
model of FIT2, we generated an antibody (anti-FIT2 LL2) to the
second luminal loop of FIT2 (Fig. S4). Wild-type and FLL mutant
FIT2 were expressed in HEK293 cells followed by digitonin
permeabilization of the plasma membrane and digested with
trypsin for various times. Limited trypsin digestion of FIT2
resulted in the appearance of two fragments designated P1 and P2
(Fig. 5). It is important to note that full length FIT2 is reduced in
its entirety to P1 at the 10 min time point of digestion, but a
Figure 2. A, Indirect immunofluorescence microscopy of FIT2-V5 FNF insertions. Cells expressing various FIT2-V5 FNF mutants were fixed,
permeabilized with digitonin with or without Triton X-100, and were incubated with FLAG antibody to detect the FLAG epitope. Cytosolic-oriented
loops are detected in digitonin-permeabilized cells. Luminal-oriented loops are detected in cells permeablized with Triton X-100. B, Indirect
immunofluorescence microscopy of FIT1-V5 FNF insertions. Cells were treated as in A, except that cells expressing FIT1-V5 without an FNF insertion
were incubated with a V5 antibody to determine the orientation of the C-terminus. Images are representative of three independent experiments
(scale bar: 5 mm).
doi:10.1371/journal.pone.0010796.g002
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indicating that generation of P1 precedes the generation of P2.
Importantly, the amount of the 15 kD P2 fragment of the FLL
mutant is increased compared to the P2 fragment generated from
wild-type FIT2, indicating a conformational change in FLL
relative to wild-type FIT2. When blots were re-probed with an
antibody to the C-terminal 13 amino acids of FIT2, an epitope
that is localized to the cytosol, both FLL mutant and wild-type
were digested to similar levels in the presence of trypsin (Fig. 5,
bottom panel, lanes 3–6). Importantly, FLL mutant and wild-type
FIT2 were expressed to similar levels (Fig. 5, lanes 1 and 2).
We next wanted to determine the cleavage sites of FIT2 that
gave rise to the P1 and P2 fragments. Since trypsin cleaves C-
terminal to lysine and arginine, we generated alanine mutations in
cytosolic lysines and arginines in FIT2-V5 and screened for
changes in P1 and P2 fragment sizes. Mutagenesis of K240 did not
alter the molecular weight of the P1 fragment, despite being
expressed to lower levels than wild-type FIT2. Mutation of K256
or R257 resulted in an increased molecular weight of P1 fragment
compared to wild-type FIT2, indicating that both K256 and R257
are cleaved by trypsin and likely constitute the C-terminus of the
P1 and P2 fragment (Fig. 6A). Mutation of K86 resulted in a P2
fragment having a smaller molecular weight compared to wild-
type FIT2 (Fig. 6B). Mutation of R92 resulted in a further, minor
reduction in molecular weight of P2 compared to wild-type, that is
likely consistent with cleavage at R93. Mutation of R93 did not
affect the molecular weight of the P2 fragment and resulted in a P2
fragment of similar molecular weight as found in wild-type,
indicating that R93 is not a cleavage site in wild-type FIT2 and
that R93 is likely utilized only in the R92A mutant, but not in
wild-type FIT2 (Fig. 6B). Cleavage at K177 or K180 is unlikely
because this would result in a P2 fragment having a molecular
weight of approximately 9 kD. Indeed, mutation of these residues
did not result in a change in molecular weight of the P2 fragment
(Fig. 6C). Taken together, these data indicate that the N- and C-
terminus of the P2 fragment is likely generated by cleavage at K86
and K256/R257, respectively (Fig. 6D), and since the generation
of P1 precedes the generation of P2, the conformational change
occurring in the FLL mutant likely occurs around residue K86
leading to increased trypsin susceptibility at K86. Since these
studies to identify the trypsin cleavage sites utilized V5-tagged
FIT2 constructs, as a control we wanted to test whether the V5 tag
could influence the tryptic pattern seen in the FLL mutant.
Importantly, the FLL-V5 tagged construct also showed an
increased amount of P2 fragment compared to FIT2-V5 wild-
type (Fig. S5). In summary, these results indicate that the FLL
mutant has a conformational change relative to wild-type FIT2
that resulted in a gain-of-function phenotype.
Discussion
FIT1 and FIT2 constitute a novel family of evolutionarily
conserved proteins that do not share sequence similarity to known
proteins or domains and have a unique function [12]. FIT proteins
are exclusively located in the endoplasmic reticulum membrane,
the presumed site of lipid droplet formation, and are not found on
lipid droplets. In a previous study, we showed that FIT proteins
mediate the partitioning of triglyceride into cytosolic lipid droplets
without mediating triglyceride biosynthesis. However, the mech-
anism by which FIT proteins partition triglyceride into lipid
droplets is not known. Our goal in the present study was to gain an
understanding of this mechanism by experimentally solving the
topological model of FIT proteins and determining the functional
relevance of evolutionarily conserved residues. We found, by using
two separate methods, glycosylation site insertion, and indirect
immunofluorescence, that both FIT1 and FIT2 have six
transmembrane domains with both N- and C-termini located in
the cytosol. This topological model of FIT1 and FIT2 bears
resemblance to the topology of the Insig family of ER-resident
membrane proteins involved in regulating sterol homeostasis [16].
Comparative sequence analysis revealed a highly conserved
tract of residues located in transmembrane domain 4 that we
designated the ‘‘FIT signature sequence.’’ In order to understand
the functional role of the FIT signature sequence we made alanine
substitutions of individual or combinations of residues of the
signature sequence in FIT2. Our rationale for focusing on FIT2
rather than FIT1 was that FIT2 is the anciently conserved
homolog of the FIT family and is ubiquitously expressed in
mammalian cells and tissues. Alanine replacements of residues
comprising L164, MIV165–167, E168, or E169 resulted in loss of
function and protein instability (D. Gross and D. Silver,
unpublished observations). Without structural information of
FIT2, these mutations are not functionally informative. However,
alanine substitution of FLL157–159 (designated FLL) resulted in a
gain-of-function when expressed in cells, making this mutant
informative in ascertaining FIT2 function. Cells expressing this
mutant version of FIT2 exhibited a 5-fold increase in both lipid
droplet number and size, but only a 1.8-fold increase in cellular
triglyceride relative to wild-type FIT2. The finding that cells
expressing the FLL mutant relative to wild-type FIT2 had a
Figure 3. A conserved tract of amino acids in transmembrane
domain 4 of FITs. Alignment of partial sequences of FIT2 and FIT1
from various species showing the ‘‘FIT signature sequence’’ is indicated
within the red box. The most conserved group of residues in this
domain comprises the FLL sequence, whose hydrophobic character was
retained throughout evolution. Based on our experimentally deter-
mined topological model of FIT proteins (Figure 1 and 2), the FIT
signature sequence is located in transmembrane domain 4.
doi:10.1371/journal.pone.0010796.g003
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compared to total cellular triglyceride levels is not surprising and
is explained by the observation that FIT2 does not mediate
triglyceride biosynthesis but rather the re-distribution or parti-
tioning of cellular triglycerides into lipid droplets [12]. The modest
increase in cellular triglycerides in cells expressing FIT2 is similar
to what has been described in cells expressing the lipid droplet
protein perilipin, which dramatically enhances lipid droplet
accumulation in cells disproportionately to total cellular triglycer-
ide accumulation without augmentation of triglyceride biosynthe-
sis [21]. It is likely that the half-life of triglyceride in lipid droplets
is longer than in cellular membranes, giving rise to modest
increases in cellular triglycerides in response to FIT overexpres-
sion.
We hypothesized that the FLL mutant has an altered
conformation relative to wild-type FIT2. We used limited trypsin
digestion to test this hypothesis. To perform this method, which
has been used successfully to study lipid-induced changes in two
other ER resident membrane proteins, HMG-CoA Reductase and
SCAP [19,20], we needed to develop an antibody to a luminal
Figure 4. FLL(157-9)AAA FIT2-V5 is a gain-of-function mutant. A, Confocal fluorescence microscopy of lipid droplets in HEK293 cells
transiently transfected with wild-type FIT2-V5 (WT), FLL(157-9)AAA FIT2-V5 (designated FLL), human DGAT2, or mock transfected control. Images are
representative of three independent experiments. Cells were stained for lipid droplets (green) and FIT2-V5 (red), and nuclei (blue). B, Histogram of
lipid droplet volumes. HEK293 cells were set up as in A and subjected to confocal fluorescence microscopy. Z-stacks were captured and 3D
renderings were constructed. Data was analyzed using Velocity software (Perkin Elmer). Analysis was performed on 10 independent 3D renderings




27, respectively). The data are presented as mean 6 s.d. D, Quantification of cellular triglyceride concentration in cells expressing the indicated
constructs. DGAT2 or mock transfected were used as positive and negative controls, respectively. The data are presented as fold-increase over mock
control and are representative of three independent transfections.
doi:10.1371/journal.pone.0010796.g004
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model of FIT2, we developed antibodies to the second luminal
loop of FIT2. Our studies revealed that trypsin digestion of FIT2
and the FLL mutant resulted in a trypsin resistant fragment of
,15 kDa (designated P2) due to cleavage at K86 and K256/
R257. Importantly, the amount of P2 fragment generated by
digestion of the FLL mutant was increased relative to wild-type
FIT2, indicating an altered conformation of this mutant. We
interpret these findings to indicate that the FLL residues in
transmembrane domain 4 stabilize a specific conformation that
attenuates or regulates FIT2 activity. Substitution of these large
non-polar side chains with methyl groups either increases solvent
accessibility around K86 and/or permits greater antibody affinity
in the second luminal loop of FIT2, as indicated in limited trypsin
digestion experiments, correlating with increased FIT2 activity
(Fig. 7). It is tempting to speculate that the activity of wild-type
FIT2 is regulated by conformational changes induced by ER
membrane lipids or interaction with other ER proteins. Such
modes of regulation have been clearly demonstrated for Insig,
SCAP and HMG-CoA Reductase [22,23]. Whether FIT2 is
similarly regulated will require further study into this recently
identified family of proteins.
Materials and Methods
Plasmid constructs
V5/His6-tagged murine FIT1 or FIT2 in the pcDNA3.1-V5/
His6 vector (Invitrogen Corp) were used as a template for all
mutagenesis reactions. Insertion of FLAG tags flanking NGT
glycosylation consensus sequences (FLAG-NGT-FLAG, FNF tags)
or generation of FLL157–159AAA was performed by designing
primers for overlap-extension PCR. All desired mutations were
verified by sequence analysis.
Generation of anti-LL2 FIT2 antibody
Polyclonal antibodies were raised in rabbit against 15 amino
acids from the second luminal loop of FIT2 (ALEGIR-
QEHRSKQQC) and validated for specificity by using lysates
from HEK293 cells expressing FIT2 (Fig. S4).
Cell culture and transfection of cell
HEK293 cells from the American Type Tissue Culture
Collection were culture in Dulbecco’s modified Eagle’s medium
(DMEM) with 10% Fetal Bovine serum (FBS) and 1X penicillin/
streptomycin (DMEM-FBS) at 37uC with 5% CO2. Transient
transfections were performed using Lipofectamine 2000 according
to manufacturer’s instructions (Invitrogen Corp.).
PNGasF treatment
HEK293 cells were plated, and transiently transfected with
indicated wild-type or FNF FIT1-V5 or FIT2-V5 constructs on
day 0. 18 hrs post-transfection, cell lysates were prepared and 10 mg
of protein from each lysate was digested with or without 10,000 units
of PNGaseF (New England Biolabs) for 1 hr at 37uCa c c o r d i n gt o
Zelenski et al. [24]. Samples were not boiled prior to PNGaseF
treatment. Reactions were stopped by addition of Laemmli buffer
and analyzed by immunoblot analysis using anti-V5 antibody.
Immunoblot analysis
Samples were separated by SDS-PAGE on 10, 12, or 15%
polyacrylamide gels, transferred to nitrocellulose membranes (Bio-
Rad) and incubated with indicated antibodies.
Indirect immunofluorescence microscopy
HEK293 cells were plated on 25-mm glass bottom dishes
(Willco), transfected and allowed to express protein for 18 hours or
form lipid droplets for 36 hours. Cells were then washed twice
with PBS, stained with 12 mg/ml BODIPY 493/503 (Invitrogen)
in DMEM-FBS for 10 minutes at room temperature and 2.5 mg/
ml Hoechst 33342 (Invitrogen) in DMEM-FBS for 25 minutes at
room temperature where indicated. Cells were then washed twice
more with PBS and fixed for 15 minutes at room temperature in
3.7% methanol-free formaldehyde in PBS. Cells were washed
twice again with PBS and permeabilized sequentially in PBS with
20 mM digitonin for 1.5 minutes with or without 0.1% Triton X-
100 for 3 minutes at room temperature. Cells were washed three
times with PBS between and after permeabilization procedures.
Following selective permeabilization, cells were blocked with 5%
filtered goat serum in PBS for 10 minutes at room temperature.
Post-blocking, cells were incubated for 1 hour at room-tempera-
ture in PBS with 1:400 dilution of rabbit anti-calnexin C-terminus
(Sigma-Aldrich), rabbit anti-calnexin N-terminus (Stressgen),
mouse anti-FLAG (Sigma-Aldrich), rabbit anti-LL2 FIT2, and/
or mouse anti-V5 (Invitrogen Corp) antibodies. Cells were washed
three times in PBS and incubated with 1:500 dilution of goat anti-
rabbit or donkey anti-mouse AlexaFluor488, AlexaFluor562 or
AlexaFluor680. Cells were washed three more times, resuspended
in PBS and analyzed on an Olympus IX81 electronically
motorized fluorescence microscope with a 60X N.A. 1.4 Phase 3
objective.
Figure 5. FLL(157-9)AAA FIT2 has an altered conformation
compared to wild-type FIT2. FLL(157-9)AAA FIT2 (FLL) and FIT2 (WT)
were transfected into cells and limited trypsin digestion time-courses
were performed on both of these constructs. Results were analyzed by
Western blot using antibodies directed to the luminal loop 2 of FIT2
(designated anti-LL2) and the C-terminus (designated anti-C-term). FLL
was expressed to similar levels as WT (lanes 1 and 2). Two proteolytic
products were detected and designated P1 and P2. The amount of P2 is
increased for FLL following trypsin digestion. As a control for the
efficiency of digestion of each construct, blots were reprobed with the
anti-C-term antibody (lower panel) that detects the cytosolic-localized
FIT2 C-terminus. FL designates full length FIT2. The Western blots
shown are representative of three independent experiments.
doi:10.1371/journal.pone.0010796.g005
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HEK293 cells were plated on 25-mm glass bottom dishes,
transfected (mock, FIT2-V5, FLL, or DGAT2), and allowed to
form lipid droplets for 36 hours. Cells were fixed and processed for
indirect immunofluorescence detection of FIT2-V5, then treated
with 12 mg/ml BODIPY 493/503 (Invitrogen Corp) in DMEM-
FBS for 10 minutes at room temperature and 2.5 mg/ml Hoechst
33342 (Invitrogen Corp) in DMEM-FBS for 25 minutes at room
temperature. Cells were then washed twice in PBS. A Zeiss Live/
DuoScan confocal microscopy using a 63X NA=1.4 OIL
objective and AIM 4.2 software was used to generate z-stacks
and reconstruct three-dimensional projection images of cells. 10
random fields were examined and 100 optical z-sections were
generated for each field. Both lipid droplet volumes and lipid
droplet number per cell expressing FIT2 (based on detection of
V5) were quantified using Velocity software (Perkin Elmer). The
threshold for identifying lipid droplets was established as intensities
greater than 20% of maximum intensity. This cutoff allowed the
program to eliminate non-specific, diffuse staining that is localized
to the endoplasmic reticulum and was considered background.
Quantification of total cellular triglycerides
HEK293 cells were plated in 10-cm dishes, transfected, and
allowed to form lipid droplets for 36 hours. Cells were then
washed twice with PBS and extracted twice on the plate with 3:2
hexane/isopropanol (HIP). HIP solutions were transferred to
glass-bottom tubes, dried down under a stream of nitrogen and re-
dissolved in solvent #1 and spotted onto glass silica TLC plates
(EMD Biosciences) pre-washed with 60:35:8 chloroform/metha-
nol/water. Lipid standards for various lipid species were also run
on TLC plates. The plate was run to one-third of the plate’s height
in solvent #1 (25:15:4:2) chloroform/methanol/acetic acid/water,
removed and dried completely. The plate was then run in solvent
#2 (60:40:4 heptanes/isopropyl ether/acetic acid) until the solvent
Figure 6. Mutational analysis to define the P1 and P2 fragment
trypsin cleavage sites. A, Cells were set up as in Fig. 5 by expressing
either K240A, K256A, R257A (all constructs are V5 tagged) and
compared to wild-type FIT2-V5 (WT) in limited trypsin digestion time
course assays as indicated. Additional bands were detected with the
anti-LL2 antibody due to the presence of lysine and arginine residues in
the C-terminal V5 tag. Note the molecular weight shift in the P1
fragment of K256A and R257A, but not of K240A, indicating that K256
or R257 are likely cleavage sites giving rise to P1. Also of note is the
lower amount of P2 generated in these mutants compared to wild-type
correlating with lower expression levels of these constructs. B, Cells
were set up as in A to examine the tryptic pattern of K86A, R92A and
R93A compared to wild-type. Of note are the decreased molecular
weights of the P2 fragments of K86A and R92A, but not of R93A
compared to WT, indicating that cleavage likely occurs at K86 (and
K256/R257) to generate the P2 fragment. C, Cells were set up as in A
and B. K177A or K180A did not affect the size of P2, indicating that
these residues are not cleaved by trypsin in WT FIT2. D, Topological
model showing the possible cytosolic trypsin-susceptible residues of
FIT2 in the limited trypsin digestion assay. Based on the above data,
residues in red indicate those that are cleaved to form proteolytic
products P1 and P2. Residues in blue are those that are not cleaved by
trypsin in wild-type FIT2. These data are representative of two
independent experiments.
doi:10.1371/journal.pone.0010796.g006
Figure 7. Model for conformational change in FIT2 FLL mutant.
The FIT2 FLL mutant has an altered conformation relative to wild-type
FIT2 that results in increased solvent accessibility of residues in cytosolic
loop 2 containing residue K86. This conformational change may
facilitate increased partitioning of triglyceride into nascent cytosolic
lipid droplets or allow for the creation of larger lipid droplets by
undetermined mechanisms.
doi:10.1371/journal.pone.0010796.g007
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completely and then run to one-third height in solvent #3
(45:15:10 ethyl acetate/isooctane/acetic acid). The plate was
dried, sprayed to saturation with 3% cupric-acetate/8% phospho-
ric acid in water using a glass sprayer and allowed to dry overnight
at room temperature. The TLC plate was developed by activating
the cupric acetate at 80uC for 3 minutes and immediately
transferred to 200uC in order to develop the plate until all samples
were visible. Plates were scanned and band densities were
analyzed by Quantity One 4.6.1 software image analysis software
(BioRad).
Limited trypsin proteolysis
This protocol was modified from Brown et al. [19]. Briefly,
HEK293 cells were transiently transfected in tissue culture plates
with indicated constructs on day 0 and grown in DMEM-FBS.
18 hrs post-transfection, cells were washed twice with PBS,
transferred to 1.5 ml Eppendorf tubes by agitation and pipetting,
pelleted and permeabilized for 1.5 minutes with 20 mM digitonin
dissolved in PBS containing a protease inhibitor cocktail. Cells
were washed twice more with PBS, resuspended in 500 ml PBS,
and 0.8 mg trypsin in 4 ml PBS was added where indicated and
incubated for various times at 31uC. Reactions were quenched
with 40 mg Soybean Trypsin Inhibitor (Sigma-Aldrich) in 10 ml
PBS, membranes were pelleted at 16,0006g for 1 minute at room
temperature and lysed at 4uC for 1 hour in 500 ml RIPA buffer.
Cell debris and nuclei were pelleted by centrifugation at 5,0006g
for 10 minutes at 4uC and the supernatant protein concentration
was determined by Bradford assay. For immunoblot analysis,
equivalent amounts of protein were loaded in each lane.
Statistics
All quantitative data are represented as mean 6 s.d. p values
were generated by Student t-test.
Supporting Information
Figure S1 FLAG-NGT-FLAG FIT2-V5 constructs are all
capable of forming lipid droplets. A, FIT2 constructs are designed
as in-frame fusions with carboxyl-terminal V5 and His6 tags. B,
HEK293 cells were transfected with each FIT2-V5 construct
containing FNF insertions. Mock transfected cells served as a
negative control. Cells were stained for neutral lipid and nuclei
with BODIPY493/503 and Hoechst 33342, respectively, and
analyzed by confocal microscopy, Images are representative of
three independent experiments.
Found at: doi:10.1371/journal.pone.0010796.s001 (1.14 MB TIF)
Figure S2 Indirect immunofluorescence microscopy for endog-
enous calnexin topology. A, The known topological model of ER-
resident type I integral membrane protein calnexin. B, HEK293
cells were fixed, permeabilized with digitonin with or without
Triton X-100, and were incubated with antibodies to detect either
the N- or C-terminus of endogenously expressed calnexin. The
image is representative of three independent experiments (Bar
scale: 5 mm).
Found at: doi:10.1371/journal.pone.0010796.s002 (0.75 MB TIF)
Figure S3 FLL(157-9)AAA FIT2 is properly localized to the ER.
A. HEK293 cells were transfected with wild-type FIT2-V5 (WT)
or FLL(157-9)AAA FIT2-V5 (FLL) and cell lysates processed for
Western blot analysis. Expression of WT and FLL were similar. b-
actin served as a loading control. B. HEK293 cells were
transfected with wild-type FIT2-V5 (WT) or FLL(157-9)AAA
FIT2-V5 (FLL). Cells were then processed for immunofluores-
cence microscopy and stained for FIT2 with an anti-V5 antibody,
stained for ER using an anti-C-terminus calnexin antibody and
nuclei were stained with Hoechst 33342. Images are representative
of two independent experiments (Bar scale: 5 mm).
Found at: doi:10.1371/journal.pone.0010796.s003 (1.12 MB TIF)
Figure S4 Specificity of anti-FIT2 LL2 antibody. HEK293 cells
were mock transfected or transfected with FIT2-V5, lysed, and
analyzed by Western blot using anti-FIT2 LL2. Blot was reprobed
with anti-b-actin antibody to control for loading.
Found at: doi:10.1371/journal.pone.0010796.s004 (0.70 MB TIF)
Figure S5 Limited trypsin digestion time course of FLL(157-
9)AAA and wild-type FIT2-V5. HEK293 cells were transfected
with V5-tagged FLL(157-9)AAA (FLL) and wild-type FIT2 (WT),
permeabilized with digitonin in the presence of protease inhibitors
and proteolyzed for various times with or without trypsin.
Proteolysis reactions were quenched with soybean trypsin inhibitor
(STI), lysed in its presence, and analyzed by Western blot with
anti-FIT2-LL2 antibody. Note the increase in the production of P2
by digestion of FLL-V5 compared to WT.
Found at: doi:10.1371/journal.pone.0010796.s005 (0.79 MB TIF)
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